Complex diseases like cancer are medically almost exclusively treated by combining several different drugs. These combinations are typically composed from drugs that show effect on their own, but do not necessarily constitute the best possible combinations.
The new robot system can find optimal treatment combinations and was developed by a research group led by Dr Mats Gustafsson, Professor of Medical Bioinformatics at Uppsala University.
"We have built a robot system that plans and conducts experiments with many substances, and draws its own conclusions from the results," said Dr Claes Andersson, also a leading scientist in the project.
Instead of just combining a couple of substances at a time, the new lab robot has the ability to handle on the order of a dozen drugs simultaneously. The aim for the future is to be able to handle many more, preferably hundreds.
"We are now one among the few laboratories in the world with this type of lab robot. However, so far researchers have only used the systems to look for combinations that kills the cancer cells, not taking the side effects into account," said Gustafsson.
The scientists also want to build more prior knowledge into the guiding algorithm of the robot, for example, prior knowledge about drug targets and disease pathways.
For patients with the same cancer type returning multiple times, sometimes the cancer cells develop resistance against the pharmacotherapy used.
The new robot systems may also become important in the efforts to find new drug compounds that make these resistant cells sensitive again.
An article about the robot system was published in Scientific Reports.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
